Can saffron help treat liver cancer?
Part of Cancer, Digestive system clinical trials.
This trial tests whether saffron, a natural spice, has anti-cancer effects for people with advanced liver cancer (HCC) who cannot have standard treatments like surgery, local therapy, or chemotherapy. It aims to see if saffron can help slow the cancer or improve well-being.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced liver cancer (HCC) that cannot be treated with surgery, local therapies, or chemotherapy.
- You have baseline lab results and contrast imaging available from before the study.
- You agree to participate and sign a consent form.
- You do not have any other cancers besides liver cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at whether a substance called sialic acid can help tell the difference between healthy people, those with liver scarring, and those with liver cancer. It aims to find a simple blood test for liver cancer detection.
This study tests if cannabis oil can help people with advanced liver cancer that cannot be treated with standard therapies. It is a small pilot study to see if the oil is safe and may improve symptoms or quality of life.
This trial is testing if an extract from a medicinal mushroom (Antrodia cinnamomea) can help people with liver cancer who have had a treatment called TACE (chemoembolization). It looks at whether the mushroom extract can improve liver health and recovery after the procedure.
This trial tests whether AHCC, a natural supplement, can help boost your immune system while you receive standard immunotherapy for liver cancer. Researchers want to see if it makes the treatment work better.
This study compares two treatment approaches for advanced liver cancer that has spread within the liver but not to other parts of the body. Both treatments combine chemotherapy delivered directly to the liver with immunotherapy drugs to help your immune system fight the cancer.
This trial tests a targeted radiation treatment (SIRT) for people with liver cancer that is still confined to one side of the liver and has not been treated before. The goal is to see if SIRT can shrink the tumor enough to make surgical removal possible.
Hear when a new Hepatocellular Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.